Dong, K. et al. 2019. Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma. Bangladesh Journal of Pharmacology. 14, 1 (Feb. 2019), 32–35. DOI:https://doi.org/10.3329/bjp.v14i1.38807.